Beauty Health (NASDAQ:SKIN) Stock Price Up 1.4% – Should You Buy?

Shares of The Beauty Health Company (NASDAQ:SKIN) traded up 1.4% on Monday . The stock traded as high as $0.70 and last traded at $0.6719. Approximately 565,038 shares changed hands during trading, a decline of 34% from the average session volume of 858,688 shares. The stock had previously closed at $0.6628.

Wall Street Analyst Weigh In

SKIN has been the subject of several research analyst reports. Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a research note on Friday, March 13th. Zacks Research raised Beauty Health from a “strong sell” rating to a “hold” rating in a research report on Monday, March 16th. Canaccord Genuity Group reduced their target price on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Friday, May 1st. TD Cowen dropped their price target on Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a research note on Monday, March 16th. Finally, Roth Mkm restated a “buy” rating and issued a $2.00 price objective (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $2.02.

Beauty Health Stock Performance

The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37. The firm has a market cap of $87.08 million, a PE ratio of -3.95 and a beta of 1.09. The stock’s 50 day moving average price is $0.75 and its 200 day moving average price is $1.08.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.04. The firm had revenue of $64.91 million during the quarter, compared to the consensus estimate of $66.28 million. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%. As a group, equities analysts forecast that The Beauty Health Company will post -0.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Beauty Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. grew its position in Beauty Health by 6.6% in the second quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock valued at $188,000 after acquiring an additional 6,059 shares in the last quarter. Rhumbline Advisers boosted its stake in shares of Beauty Health by 5.7% in the third quarter. Rhumbline Advisers now owns 150,124 shares of the company’s stock valued at $299,000 after purchasing an additional 8,142 shares during the period. The Manufacturers Life Insurance Company grew its holdings in Beauty Health by 33.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock valued at $79,000 after purchasing an additional 10,410 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new position in Beauty Health in the 3rd quarter worth $26,000. Finally, SG Americas Securities LLC boosted its position in Beauty Health by 111.9% in the 4th quarter. SG Americas Securities LLC now owns 24,670 shares of the company’s stock valued at $34,000 after buying an additional 13,026 shares during the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.